Filing Details
CERO THERAPEUTICS HOLDINGS, INC. (OTC:CERO) filed a Form 8-K with the Securities and Exchange Commission on July 17, 2026, disclosing a material event.
8k filedOTC:CERO
CERO THERAPEUTICS HOLDINGS, INC. (CERO) Reports Material Event to SEC
Filing Details CERO THERAPEUTICS HOLDINGS, INC. (OTC:CERO) filed a Form 8-K with the Securities and Exchange Commission on July 17, 2026, disclosing a material event. Market…
Market Context
CERO THERAPEUTICS HOLDINGS, INC.'s stock currently trades at $0.01 with a market capitalization of $108.5K. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for CERO THERAPEUTICS HOLDINGS, INC.'s stock.
All SEC filings for CERO THERAPEUTICS HOLDINGS, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CERO Stock Page
Frequently Asked Questions
Where can I read CERO's SEC filings?
Browse all filings on our CERO SEC filings page.
What types of SEC filings does CERO THERAPEUTICS HOLDINGS, INC. file?
Public companies like CERO THERAPEUTICS HOLDINGS, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.